Shandong Buchang Pharmaceuticals Co., Ltd.

SSE:603858.SS

16.84 (CNY) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -702.395151.865-1,718.1171,235.4151,843.1421,963.2281,907.4921,638.9381,769.9113,533.7021,508.7891,347.6671,251.3311,228.166
Depreciation & Amortization 618.316592.575497.562510.433424.55386.081371.901295.896286.664197.2799.54883.66222.7560
Deferred Income Tax 0-143.809-19.407-41.24915.406-76.151-37.207-78.9278.53800000
Stock Based Compensation 00000000000000
Change In Working Capital -7.64-1,739.513675.491-651.701-422.913236.045-276.201-12.847-575.14-10.80973.724-343.11900
Accounts Receivables 583.88583.677483.364363.138-648.663640.333-175.552-665.997-268.559-284.9920000
Inventory 228.76-1,185.7939.522-1,066.129-847.774-537.91372.497-269.736-207.102-140.72523.978-375.98600
Accounts Payables 0-493.591172.01392.5391,058.117209.776-135.941,001.813-108.01700000
Other Working Capital -820.285-143.809-19.407-41.24915.406-76.151-348.698256.889-368.038129.91649.74632.86700
Other Non Cash Items 1,031.669974.6223,300.691226.366113.98435.97947.64539.988187.348-1,599.43398.52125.747-1,251.331-1,228.166
Operating Cash Flow 939.951-164.262,755.6281,320.5131,958.7632,621.3342,050.8371,961.9761,668.7832,120.7311,780.5821,113.9571,349.1860
Investing Activities:
Investments In Property Plant And Equipment -196.995-529.915-543.166-433.534-536.438-662.112-1,309.833-1,455.046-677.872-480.778-204.875-510.849-543.344-378.906
Acquisitions Net 06.488-15.816-22.1421.66-20.269-0-2,801.4940.075-1,098.076-105.4710.228021.518
Purchases Of Investments -63.55-71.63-478.964-50.508-24.909-11.925-475.51-321.39-648.478-1,169.111-88-589-208-300
Sales Maturities Of Investments 2.96940010.8678.51324.61738.75293.37792.8400.5860.0957.27401.049
Other Investing Activites 8.024016.907-228.00393.351-614.63395.008178.15296.874220.724-9.571108.007-2.5295.119
Investing Cash Flow -249.552-195.058-1,010.179-655.671-421.719-1,270.188-1,596.957-4,306.978-1,189.401-2,526.654-407.822-984.34-753.864-561.22
Financing Activities:
Debt Repayment 499.337150.105-590.07438.358641.747475.44431,794-1,958313.9720660-98.7-71.3
Common Stock Issued 0000074000000000
Common Stock Repurchased 0-9.99000-740-200.0130000000
Dividends Paid -272.436-1,194.264-398.175-581.778-1,785.153-1,373.194-1,185.843-1,165.763-137.518-132.012-1,057.463-866.656-81.762-23.658
Other Financing Activities -792.11-15.527146.785-63.027-39.504412.1883.878-11.7273,671.435-5.797-173.092-192.459-421.87-19.339
Financing Cash Flow -565.21-1,069.676-987.567-770.881-1,885.984-1,225.606-938.978616.511,575.917176.091-510.555-399.114-602.332-114.297
Other Information:
Effect Of Forex Changes On Cash 0.0110.010.161-0.343-0.0140.0040.057-0.023-0.01500-000
Net Change In Cash 125.2-1,428.983758.043-106.382-348.954125.543-485.041-1,728.5152,055.284-229.832862.204-269.497-7.01876.084
Cash At End Of Period 817.533692.3332,121.3171,363.2741,469.6561,818.6111,693.0682,178.1083,906.6231,851.3392,081.1711,218.9671,485.9071,492.917